中國之信集團(08265.HK)延遲刊發中期業績
格隆匯8月5日丨中國之信集團(08265.HK)發佈公告,公司基於新任董事仍需要時間熟悉公司及其附屬公司目前的營運,並嘗試取得於中國公司附屬公司的會計記錄和相關文件;公司仍與中國律師商討就被中國公安部查封記錄和文件的事宜;公司仍與公司核數師商討其關注有關公司部分附屬公司記錄和文件事被中國公安部查封的事宜;及往返香港與內地的安排尚未解封,公司未能根據創業板上市規則於指定時間內刊發:截至2019年12月31日止年度的年度業績;截至2020年3月31日止3個月第一季度業績;截至2020年6月30日止6個月中期業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.